Evolution of cellular inflammatory pattern in induced sputum in patients with mild-moderate asthma for five years Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011
Cellular inflammatory pattern in induced sputum among patients with stable moderate or severe asthma Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases Year: 2010
Distribution of the cellular inflammatory pattern in induced sputum in an eosinophilic severe asthma population. Source: International Congress 2019 – Airway diseases and blood cells Year: 2019
The clinical, spirometric and cytological profiles of exacerbations in poorly controlled severe persistent asthmatics Source: Annual Congress 2007 - Towards controlling severe asthma Year: 2007
Differences in clinical and inflammatory characteristics between steroid-withdrawal-induced and spontaneous exacerbations in patients with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 199s Year: 2002
Concordance in temporally distinct blood and sputum inflammatory phenotypic measures in severe asthma Source: International Congress 2019 – Clinical implications of asthma management Year: 2019
Airway eosinophilia is not related to clinical and functional findings in a large group of severe refractory asthmatics Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum Year: 2006
Temporal profile and clinical utility of inflammatory markers in patients with acute exacerbation of COPD Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008
Overlapping biologic exacerbation clusters in asthma and chronic obstructive pulmonary disease have distinct sputum mediator and microbiome profiles Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018
Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 335s Year: 2001
Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019
The correlation between expression of selected inflammatory mediators in induced sputum and respiratory tests in asthma and COPD Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015
Inflammatory subtypes in cough variant asthma (CVA): assessment using induced sputum Source: Annual Congress 2007 - Asthma subphenotypes Year: 2007
Heterogeneous response of airway eosinophilia to biologics in severe asthma patients Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021
Inflammatory markers in sputum of patients with cough variant asthma Source: Eur Respir J 2002; 20: Suppl. 38, 584s Year: 2002
Cytokine regulation of the chronicle inflammation of bronchial asthma patients Source: Eur Respir J 2005; 26: Suppl. 49, 590s Year: 2005
Clinical characteristics, lung function, quality of life, exercise capacity and inflammatory biomarkers in induced sputum and serum in children and adolescents with uncontrolled severe asthma. Source: International Congress 2019 – Severe acute asthma and troublesome wheezing Year: 2019
Current control, airway inflammation, and subsequent exacerbation in patients with asthma Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010
Inflammatory phenotypes of severe exacerbation of COPD, a clinico-laboratory characterization. Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021